Synopsys, Inc. (NASDAQ:SNPS) Shares Acquired by Talbot Financial LLC

Talbot Financial LLC increased its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 24,083 shares of the semiconductor company’s stock after acquiring an additional 728 shares during the period. Talbot Financial LLC’s holdings in Synopsys were worth $11,689,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of SNPS. Parnassus Investments LLC acquired a new position in Synopsys during the 3rd quarter valued at about $633,469,000. Edgewood Management LLC grew its stake in shares of Synopsys by 18.9% in the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock worth $1,554,540,000 after purchasing an additional 487,025 shares during the last quarter. Van ECK Associates Corp grew its stake in shares of Synopsys by 26.5% in the 3rd quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock worth $791,923,000 after purchasing an additional 335,993 shares during the last quarter. Impax Asset Management Group plc boosted its holdings in shares of Synopsys by 120.2% in the third quarter. Impax Asset Management Group plc now owns 490,723 shares of the semiconductor company’s stock worth $248,497,000 after buying an additional 267,836 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in shares of Synopsys by 32.5% in the third quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company’s stock worth $531,056,000 after buying an additional 257,526 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

SNPS traded down $5.53 during midday trading on Monday, hitting $487.01. 390,169 shares of the company’s stock traded hands, compared to its average volume of 943,020. Synopsys, Inc. has a one year low of $457.52 and a one year high of $629.38. The company has a market cap of $75.28 billion, a PE ratio of 33.54, a price-to-earnings-growth ratio of 3.41 and a beta of 1.12. The stock’s fifty day simple moving average is $523.58 and its 200-day simple moving average is $528.92.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Piper Sandler decreased their target price on shares of Synopsys from $670.00 to $655.00 and set an “overweight” rating for the company in a report on Friday, December 6th. Berenberg Bank assumed coverage on shares of Synopsys in a report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 target price for the company. Rosenblatt Securities reiterated a “buy” rating and issued a $635.00 target price on shares of Synopsys in a report on Wednesday, December 4th. Robert W. Baird decreased their price target on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Finally, Redburn Atlantic started coverage on shares of Synopsys in a report on Monday. They set a “buy” rating and a $600.00 price target for the company. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Synopsys presently has an average rating of “Moderate Buy” and a consensus price target of $641.82.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.